GW Pharma CEO: Need to take dangle of extra on advantages of cannabis-derived remedy
GW Pharmaceuticals CEO Justin Gover tell about the must know extra about what cannabis-derived remedy must provide with Jim Cramer.
Inexperienced Thumb Industries talks U.S. cannabis market, social equity program
Inexperienced Thumb CEO Ben Kovler discussed a shortage in cannabis vegetation in some states east and explained Robin Hood CEO Wes Moore’s work on the board. For catch entry to…
GrowGeneration CEO seeks ‘extra sturdy’ cannabis licensing
GrowGeneration CEO and co-founder Darren Lampert joined CNBC’s Jim Cramer on Tuesday’s episode of “Wrathful Money,” explaining why he modified into as soon as optimistic on cannabis licensing all the…
Jim Cramer on the most intriguing marijuana performs on a Democratic sweep
Persist with the picks and shovels performs or the vertically built-in operators which would be the truth is winning, the “Angry Cash” host acknowledged. Subscribe to CNBC PRO for compile…
Hydrofarm CEO on how the cannabis alternate will evolve
Hydrofarm CEO Invoice Toler explained why the agriculture equipment maker expects most marijuana grow operations will happen indoors as a change of begin air. Subscribe to CNBC PRO for ranking…
Jim Cramer on investing in the cannabis and gambling sectors
CNBC’s Jim Cramer and David Faber register on the cannabis and gambling sectors.
GrowGeneration talks cruise-to-cruise growth plans for cannabis develop store
After opening 26 locations previously six months, GrowGeneration CEO Darren Lampert said the company is centered on opening stores on the East Waft. Subscribe to CNBC PRO for access to…
Cramer’s lightning round: The best cannabis play is Innovative Industrial Properties
“Mad Money” host Jim Cramer answers callers’ questions at rapid speed during Tuesday’s edition of the lightning round. Subscribe to CNBC PRO for access to investor and analyst insights: Poshmark:…
Jim Cramer discusses merging Aphria & Tilray cannabis companies
The largest cannabis company in the world will be formed when Aphria & Tilray merge. CNBC’s Jim Cramer talks to David Faber. Subscribe to CNBC PRO for access to investor…